Roseville, MN – Tuesday, January 4, 2022 – Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biotechnology company, today announced that a presentation given by management at the H.C Wainwright BioConnect Conference will be available for viewing online on Monday, January 10, 2022 at 7:00 a.m. ET. The conference will be held in a virtual meeting format.
H.C. Wainwright BioConnect Conference
Date: Monday, January 10, 2022
Time: 7:00 a.m. ET (4:00 a.m. PT)
Webcast: https://journey.ct.events/view/8b190fdb-538c-4d29-b5e0-6764f2abdfeb
To schedule a meeting with management, please reach out to investors@calyxt.com.
The presentation will be available for viewing and replay from the Investors section of Calyxt’s website at www.calyxt.com.
About Calyxt:
Calyxt (Nasdaq: CLXT) is a plant-based synthetic biotechnology company. The Company leverages its proprietary PlantSpring™ technology platform to engineer innovative materials and products for its customers to help them meet their sustainability goals. Calyxt’s diversified offerings are primarily delivered through its proprietary BioFactory™ production system. For more information, visit www.calyxt.com.
PlantSpring, BioFactory, and the Calyxt logo are trademarks of Calyxt, Inc. Any other trademarks belong to their respective owners.
Contacts:
| Calyxt Media Contact: | Calyxt Investor Relations Contact: |
| David Rosen/John Garabo/Michael Barron Argot Partners (212) 600-1902 media@calyxt.com | Sherri Spear/Cameron Willis Argot Partners (212) 600-1902 investors@calyxt.com |
| Calyxt Business Development Contact: | |
| Sarah Reiter Calyxt, Inc. (612) 427-7881 contact@calyxt.com |
